Marquet Magda 4
4 · Immix Biopharma, Inc. · Filed Jun 23, 2025
Insider Transaction Report
Form 4
Marquet Magda
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-20+33,000→ 33,000 totalExercise: $2.24Exp: 2035-06-20→ Common Stock (33,000 underlying)
Holdings
- 46,092
Common Stock
- 20,000(indirect: By LLC)
Common Stock
Footnotes (1)
- [F1]The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer.